You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
IND-enabling development of a biomimetic peptide drug for macular edema
SBC: Asclepix Therapeutics, Inc. Topic: NEISummaryMacular edemaMEand diabetic macular edemaDMEwhich affects at leastmillion people in theUSare leading causes of blindness in people between the ages ofThe major problem in thesediseases is a leaky vasculaturewhich results in pooling of blood around the retinaThis blood can causeocclusion of vision as well as swelling and increased ocular pressure and detachment of the retinaThe effective the ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
RetiVue DR, a point and shoot, non-mydriatic, widefield retinal camera for diabetic eye screening
SBC: RETIVUE LLC Topic: NProject Summary Over the past two decadesdiabetic retinopathyDRhas become the leading cause of adult blindness in the USaffectingof all diabetic patients and resulting in $million a year in direct medical costsVision loss due to DR is largely preventable and can be reduced by up towith appropriate eye screeningHoweverin the USless thanof diabetic patients receive a recommended yearly eye exam due ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development and Commercialization of Predictive Biomarker Panel and In Office Kit for the Management of Diabetic Macular Edema
SBC: OCULAR PROTEOMICS, LLC Topic: NAbstract Diabetic Macular Edema DME is a vision threatening stage in Diabetic Retinopathy DR that can result in legal blindness The biochemical mechanisms that drive DME progression are not well understood and treatments address only portions of the disease pathology The available treatment options vary widely from injectable anti VEGF to injectable steroids to laser treatments and carry a ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia
SBC: AAVOGEN INC Topic: 102PROJECT SUMMARY. The skeletal muscle wasting that occurs with cancer cachexia compromises quality of life and is both directly and indirectly responsible for cancer mortalities. Tumor-derived and tumor-responsive factors as well as many therapeutics themselves contribute to the cachectic state, although nutritional support has little if any positive effect on restoring striated muscle mass or func ...
SBIR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Plasma Based Microsatellite Instability Diagnostic for Guiding Immunotherapy
SBC: Personal Genome Diagnostics Inc. Topic: 102Abstract Immune checkpoint inhibitors have recently emerged as a revolution in cancer care providing the potential for durable response and improved survival for numerous cancer patients across multiple cancer types However only of patients who are treated with checkpoint inhibitors have responded in most cancer types necessitating biomarker assays that can reliably and accurately ident ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Development of a companion diagnostic to predict response to cetuximab in patients with head and neck squamous cell carcinoma
SBC: Biomarker Strategies, LLC Topic: 100ABSTRACT Head and neck squamous cell carcinoma HNSCC is the world s th leading cause of cancer accounting for of cancer mortality For many other cancers molecular characterization has led to sub classification of disease based on the status of oncogenic drivers in signal transduction pathways leading to the development of molecularly targeted agents MTAs targeting specific dysregulate ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Targeted Nanomedicine Delivering MicroRNA-30-5p ReplacementTherapy for Multi-drug Resistant Cancer Treatment
SBC: MIRECULE INC Topic: NCIAbstractIn this SBIR application miRecule proposes to develop a microRNA based therapeutic mimic of miRpmiRecule candidate MCfor the treatment of multi drug resistantMDRcancersHead and Neck Squamous Cell CarcinomaHNSCCis theth most common form of cancerGreater than half of patients present with late stage III or IV diseasewith an averageyear survival rate ofHNSCC tumors have high levels of genetic ...
SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Polyionic Papillomavirus like Particles VLP for the Treatment of HPV oropharyngeal squamous cell carcinomas OPCs
SBC: PATHOVAX LLC Topic: 102The broader impact commercial potential of PathoVax s STTR phase I proposal is to improve outcomes of cancer immuno therapy utilizing a vaccine formulation combining an immunogenic chimeric virus like particle cVLP vaccine with FDA approved immune check point inhibitors PathoVax proposes to develop this technology for treatment of human papillomavirus HPV associated cancers However cancer ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Knowledge and Usage of Lactation using Education and Advice from Support Network KULEA NET
SBC: BENTEN TECHNOLOGIES, INC. Topic: NIMHDPROJECT SUMMARY ABSTRACT Breastfeeding has the potential to reduce health disparities associated with infant mortality and morbidity Breastfeeding rates by ethnicity in the United States show a marked disparity in African American AA women as compared to other groups Barriers to breastfeeding are complex with literature citing a lack of knowledge poor family and social support inhibiting soc ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Systematic Medical Approach to Reward Transformation SMART for Brain Health in Opioid Use Disorder
SBC: Versa Integrated Solutions, Inc. Topic: 102Summary In recent years opioid use disorder OUD and deaths due to opiate overdose e g with heroin fentanyl oxycodone in suburban and rural non minority groups has created an urgency for approaches to stem this epidemic but the rise in OUD and opiate overdose deaths has occurred in inner cities at similar rates Heroin misuse and addiction are persistent problems in African American commu ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health